When Medicare Payment Advisory Commission Principal Policy Analyst Nancy Ray began her 2 September presentation on ideas to overhaul the federal payment system for physician-administered drugs in Medicare Part B, she noted a major development since the commissioners last assembled.
“Since the June report, the Inflation Reduction Act contains changes to Part B drug payment,” Ray said. “However,” she added,...






